Loading viewer...
conference
Format: PDF conference
Immunovant presented at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024, showcasing its pipeline of targeted therapies for autoimmune diseases. The presentation discusses the development of batoclimab and IMVT-1402, highlighting their potential as first-in-class or best-in-class candidates across multiple autoimmune indications.
conference
38 Pages
URB Investments Limited
Regeneron Pharmaceuticals 2023 ASH Hematology Investor Event
conferenceconference
43 Pages
Regeneron Pharmaceuticals, Inc.
Calumet Specialty Products 2023 Wells Fargo Midstream Utilities
conferenceconference
20 Pages
Calumet Specialty Products Partners
Regeneron Pharmaceuticals 2023 JPMorgan Healthcare Conference Strategy Update
conferenceconference
37 Pages
Regeneron Pharmaceuticals, Inc.